多发性骨髓瘤中的多发性肺外质细胞瘤:来自三级中心的15年经验
Sorina Badelita1, Sinziana Barbu1,2, Camelia Dobrea1,2
1Clinical Department I, Hematology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Cancers
|January 10, 2026
概括
在多发性骨髓瘤中,特别是在多发性骨髓瘤和肺部区域的外骨髓参与表明具有不良预后的侵袭性癌症. 早期诊断和新的治疗策略对于改善这些患者的生存率至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
背景情况:
- 在多发性骨髓瘤中,外骨髓参与意味着一种侵略性的疾病表型.
- 多发性骨髓瘤的胸部表现很少见,并且不太了解.
- 这项研究侧重于多发性骨髓瘤患者的多发性肺外骨髓瘤疾病.
研究的目的:
- 描述多发性骨髓瘤中多发性肺外膜干涉的临床表现,预后因素和生存结果.
- 评估多发性骨髓瘤队列中胸部表现的发生率和影响.
主要方法:
- 对34名患有多发性骨髓瘤的患者进行了回顾性,单中心的研究.
- 通过成像 (CT/MRI),细胞学,免疫类型和组织病理学证实了诊断.
- 对患者人口统计,疾病特征,预后标志物和生存数据的分析.
主要成果:
- 肺外骨干干涉的发生率为1.6% (34/2012名患者).
- 大多数病例 (73.5%) 在复发时发展,通常呈现为多流液 (70.6%).
- 预后不良的标志物包括升高的β2-微型球蛋白和LDH;细胞遗传异常是常见的. 平均整体生存时间为16个月;2年生存率为25%,没有5年生存者.
结论:
- 在多发性骨髓瘤中,多发性肺外膜干扰与积极的临床过程和不良预后有关,特别是在复发时.
- 升高的β2-微球蛋白,LDH和特定的细胞遗传异常与不良结果有关.
- 个性化治疗和新的治疗策略对于改善受影响患者的存活率至关重要.
更多相关视频
07:54Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
7.3K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
相关概念视频
01:31Pulmonary Tuberculosis III
921
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
921
01:28Pleural Effusion II: Symptoms and Management
642
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
642
01:28Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
01:25Pleural Effusion I: Introduction
3.9K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
3.9K